New

PharmaDirections

The AI engine Fit Assessment

Beta

The company provides technology-enabled, full-spectrum pharma drug development services (from discovery to regulatory approval) for biotech and pharma clients, which aligns with the central Pharma tech space requirement.

Blurb

PharmaDirections are drug development solution built on superlative scientific.

HQ Location

Cary (United States)

Founded

2003

Employees

51 - 200

Total funding raised

Not available

Funding Status

Acquired by Danforth Advisors, August 2025

Bringing a new therapy to market is complex. PharmaDirections simplifies the process, guiding biotech and pharma companies through drug development efficiently, strategically, and cost-effectively.



As pioneers of the virtual biotech model, we have unique insights & visibility into the Biotech Ecosystem. We offer full-spectrum drug development expertise, from early discovery to regulatory approval, without the overhead of a full in-house team. Our partnership approach ensures senior-level expertise exactly when and where you need it, with hands-on program leadership that keeps projects on track.



Proven Success



✔ $50M+ annual outsourced contract work managed

✔ 45+ patents/applications generated for our partners

✔ 150+ successful biotech collaborations



How We Help



✅ PRECLINICAL & CLINICAL STRATEGY – Translating science into a clear, regulatory-ready path to approval



✅ CMC & FORMULATION – Ensuring scalable, regulatory-compliant drug development



✅ REGULATORY & IP STRATEGY – Guiding IND, NDA, and global filings while safeguarding innovation



✅ FULL PROGRAM MANAGEMENT – Seamlessly integrating with your team for hands-on execution



Our expertise spans small molecules, biologics, gene therapies, and drug-device combinations across multiple therapeutic areas.



📩 Contact Cathi Clark: CClark@pharmadirections.com